Related Experiment Video
Updated: Feb 9, 2026

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification BiCAP
Published on: June 15, 2018
CD47-signal regulatory protein α signaling system and its application to cancer immunotherapy
Yoji Murata1, Yasuyuki Saito1, Takenori Kotani1
1Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Japan.
Abstract:
Tumor cells evade immune surveillance through direct or indirect interactions with various types of immune cell, with much recent attention being focused on modifying immune cell responses as the basis for the development of new cancer treatments. Signal regulatory protein α (SIRPα) and CD47 are both transmembrane proteins that interact with each other and constitute a cell-cell communication system. SIRPα is particularly abundant in myeloid cells such as macrophages and dendritic cells, whereas CD47 is expressed ubiquitously and its expression level is elevated in cancer cells. Recent studies have shown that blockade of CD47-SIRPα interaction enhances the phagocytic activity of phagocytes such as macrophages toward tumor cells in vitro as well as resulting in the efficient eradication of tumor cells in a variety of xenograft or syngeneic mouse models of cancer. Moreover, CD47 blockade has been shown to promote the stimulation of tumor-specific cytotoxic T cells by macrophages or dendritic cells. Biological agents, such as Abs and recombinant proteins, that target human CD47 or SIRPα have been developed and are being tested in preclinical models of human cancer or in clinical trials with cancer patients. Preclinical studies have also suggested that CD47 or SIRPα blockade may have a synergistic antitumor effect in combination with immune checkpoint inhibitors that target the adaptive immune system. Targeting of the CD47-SIRPα signaling system is thus a promising strategy for cancer treatment based on modulation of both innate and acquired immune responses to tumor cells.
Insights
Blocking the CD47-SIRPα pathway enhances immune cell activity against cancer cells. This approach shows promise for new cancer treatments by boosting both innate and adaptive immune responses.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Tumor cells evade immune surveillance by interacting with immune cells.
- The CD47-SIRPα axis is a key cell-cell communication system involved in immune evasion.
- CD47 is upregulated on cancer cells, while SIRPα is abundant on myeloid immune cells.
Purpose of the Study:
- To investigate the therapeutic potential of targeting the CD47-SIRPα interaction in cancer treatment.
- To evaluate the impact of CD47-SIRPα blockade on immune cell-mediated tumor cell clearance.
- To explore combination strategies involving CD47-SIRPα blockade and immune checkpoint inhibitors.
Main Methods:
- Utilizing biological agents like antibodies and recombinant proteins to block CD47 or SIRPα.
- Testing blockade strategies in in vitro assays and in vivo preclinical cancer models (xenograft and syngeneic).
- Assessing enhancement of phagocytic activity and stimulation of cytotoxic T cells.
Main Results:
- CD47-SIRPα blockade significantly enhances macrophage phagocytosis of tumor cells in vitro.
- Blockade leads to efficient tumor cell eradication in various mouse cancer models.
- CD47 blockade promotes the activation of tumor-specific cytotoxic T cells by antigen-presenting cells.
- Preclinical studies suggest synergistic antitumor effects when combined with immune checkpoint inhibitors.
Conclusions:
- Targeting the CD47-SIRPα signaling pathway is a promising cancer immunotherapy strategy.
- Modulating this axis enhances both innate (phagocytosis) and adaptive (T cell) immune responses against tumors.
- Combination therapies involving CD47-SIRPα blockade offer potential for improved cancer treatment outcomes.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Endocrine Signaling
Yeast Signaling
Bacterial Signaling
What is Cell Signaling?
Paracrine Signaling

